BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6452679)

  • 1. Factual or artificial inhibition of fibrinolysis and the occurrence of venous thrombosis in 3 cases of Behçet's disease.
    Kluft C; Michiels JJ; Wijngaards G
    Scand J Haematol; 1980 Nov; 25(5):423-30. PubMed ID: 6452679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet function, blood coagulation and fibrinolysis in Behcet's syndrome.
    Stathakis NE; Economopoulos TC; Papayannis AG; Thomopoulos D
    Blut; 1977 Mar; 34(3):215-22. PubMed ID: 843627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin.
    Espinosa G; Font J; Tàssies D; Vidaller A; Deulofeu R; López-Soto A; Cervera R; Ordinas A; Ingelmo M; Reverter JC
    Am J Med; 2002 Jan; 112(1):37-43. PubMed ID: 11812405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Parameters of hemostasis in Behçet's disease].
    Dupuy E; Tobelem G; Bourgeois P; Soria C; Pellerin A; Bellucci S; Caen JP
    Rev Med Interne; 1983 Dec; 4(4):317-21. PubMed ID: 6665348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective fibrinolysis in Behçet's syndrome: significance and possible mechanisms.
    Aitchison R; Chu P; Cater DR; Harris RJ; Powell RJ
    Ann Rheum Dis; 1989 Jul; 48(7):590-3. PubMed ID: 2505697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the fibrinolytic system in Behçet's disease?
    Asbeck F; Meyer-Boernecke D; van de Loo J
    Haemostasis; 1977; 6(5):303-9. PubMed ID: 598751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behçet's disease with decreased fibrinolysis and superior vena caval occlusion.
    Chajek T; Fainaru M
    Br Med J; 1973 Mar; 1(5856):782-3. PubMed ID: 4694434
    [No Abstract]   [Full Text] [Related]  

  • 8. Decreased fibrinolysis in Behçet's disease.
    Chajek T; Aronowski E; Izak G
    Thromb Diath Haemorrh; 1973 Jun; 29(3):610-8. PubMed ID: 4761829
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fibrinolytic activity in Behçet's disease].
    Kogure M; Motoji K
    Nippon Ganka Gakkai Zasshi; 1972 Mar; 76(3):114-21. PubMed ID: 4261805
    [No Abstract]   [Full Text] [Related]  

  • 10. Coagulation and fibrinolytic activity in Behçet's disease.
    Hampton KK; Chamberlain MA; Menon DK; Davies JA
    Thromb Haemost; 1991 Sep; 66(3):292-4. PubMed ID: 1745999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasma coagulation and fibrinolysis parameters in patients with vascular Behçet's disease, and analysis of the multimeric structure of von Willebrand factor (vWF)].
    Kagawa H; Okubo S
    Ryumachi; 1993 Oct; 33(5):416-23. PubMed ID: 8256164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unchanged global fibrinolytic capacity despite increased factor VIIa activity in Behçet's disease: evidence of a prethrombotic state.
    Ozatli D; Sayinalp N; Büyükaşik Y; Karakuş S; Haznedaroglu IC; Kirazli S; Ozcebe O; Dündar SV
    Rheumatol Int; 2002 Jan; 21(4):137-40. PubMed ID: 11843168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on fibrinolytic activity in Behçet's disease. 3. An approach by affinity chromatography (author's transl)].
    Saito K
    Nippon Ganka Gakkai Zasshi; 1973 Sep; 77(9):1443-51. PubMed ID: 4271707
    [No Abstract]   [Full Text] [Related]  

  • 14. [Is Behçet's disease associated with characteristic abnormalities of coagulation and fibrinolysis? Apropos of 70 case reports].
    Conard J; Horellou MH; Wechsler B; Fassin D; Bletry O; Godeau P; Samama M
    J Mal Vasc; 1988; 13(3):257-61. PubMed ID: 3171405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood coagulation and fibrinolysis in patients with Behçet's disease].
    Fusegawa H; Ichikawa Y; Tanaka Y; Miyachi Y; Kawada T; Gondo K; Ikeda M; Shimizu H; Arimori S; Ando Y
    Rinsho Byori; 1991 May; 39(5):509-16. PubMed ID: 2072574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin activatable fibrinolysis inhibitor in Behçet's disease.
    Donmez A; Aksu K; Celik HA; Keser G; Cagirgan S; Omay SB; Inal V; Aydin HH; Tombuloglu M; Doganavsargil E
    Thromb Res; 2005; 115(4):287-92. PubMed ID: 15668188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The functioning of the fibrinolytic system in Behçet's syndrome].
    Asbeck F; Meyer-Boernecke D; van de Loo J
    Verh Dtsch Ges Inn Med; 1978; (84):1359-62. PubMed ID: 741967
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vascular manifestations of Touraine's great aphtosis (Behcet's syndrome)].
    Faure M; Colomb D
    Sem Hop; 1978 Apr; 54(9-12):432-6. PubMed ID: 210514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Subclinical pro-thrombotic state in a relapse of Behcet's disease--case report].
    Undas A; Pinis G
    Pol Arch Med Wewn; 1996 Sep; 96(3):258-62. PubMed ID: 9122017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Behçet's disease: a vascular function study by the venostasis test and DDAVP infusion].
    Le Roux G; Guillevin L; Casassus P; Gayraud M; Limon S
    Rev Med Interne; 1985 Mar; 6(2):111-5. PubMed ID: 3923585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.